A smaller cohort published by Baert showed that in patients receiving 5 mg/kg infliximab for induction, 61% developed antibodies. with 26% of placebo patients reached the primary end point of
ROCK inhibitors
A smaller cohort published by Baert showed that in patients receiving 5 mg/kg infliximab for induction, 61% developed antibodies. with 26% of placebo patients reached the primary end point of